Paul F. Robbins

National Institutes of Health — United States

Immunology and Microbiology · Life Sciences

91h-index43.1kcitations310works11.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(197), CAR-T cell therapy research(195), Cancer Immunotherapy and Biomarkers(111), Immune Cell Function and Interaction(51), T-cell and B-cell Immunology(48)

Publications305 total

Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
Cancer Immunology Immunotherapy·2025Open Access
Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes for Metastatic Acral Lentiginous Melanoma
Journal of Clinical Oncology·2025· 1 cited
Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
Nature Medicine·2025· 4 cited
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
Nature Medicine·2025· 35 citedOpen Access
Utilization of primary tumor samples for cancer neoantigen discovery
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
Immunology of Melanoma
2024
Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens
Science Advances·2024· 14 citedOpen Access
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
Nature Medicine·2024· 62 cited
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes
Journal for ImmunoTherapy of Cancer·2024· 27 citedOpen Access
Abstract 1: Biomarkers of response and acquired resistance to TIL-ACT in solid tumors
Cancer Research·2024
Determining Optimal Placement of Copy Number Aberration Impacted Single Nucleotide Variants in a Tumor Progression History
2024Open Access
Adoptive transfer of T lymphocytes retrovirally transduced to express personalized neoantigen reactive T cell receptors can mediate tumor regression in patients with metastatic colorectal cancer
2024Open Access
Determining Optimal Placement of Copy Number Aberration Impacted Single Nucleotide Variants in a Tumor Progression History
Lecture notes in computer science·2024
Abstract B007: Phenotypic Signatures of Circulating Neoantigen-Reactive CD8+ T Cells in Patients with Metastatic Cancers
Cancer Immunology Research·2023
Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
Cancer Cell·2023· 69 citedOpen Access
1216 Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
Regular and Young Investigator Award Abstracts·2023Open Access
Data from Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
Supplementary Data from Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
Supplementary Data from Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
Supplementary Data from Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
page 1 of 16Next →

Frequent Co-authors

Steven A. Rosenberg(45), Mark E. Dudley(17), John R. Wunderlich(14), Yong F. Li(14), Jared J. Gartner(13), Nicholas P. Restifo(12), Mona El‐Gamil(12), Maria R. Parkhurst(11), Yong‐Chen Lu(10), Zhili Zheng(10), Richard M. Sherry(9), Eric Tran(9), James Chih‐Hsin Yang(8), Marybeth S. Hughes(8), Steven A. Feldman(8), Todd D. Prickett(8), Udai S. Kammula(7), James C. Yang(7), Yutaka Kawakami(7), Stephanie L. Goff(7)